Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19
Most trials used 3-5g/day
Even Avecho Biotechnology (formerly Phosphagenics), a company who wanted to repurposed AOD-9604 as a transdermal formulation, knew why the clinical trials failed: AOD9604s delivery could have been the key issue
Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts Link : PubMed 25415472 Summary : In rat tendon fibroblasts, BPC-157 dose- and time-dependently increased growth hormone receptor expression, boosting cell proliferation (via MTT assay and PCNA) when combined with growth hormone, supporting tendon healing
Focusing on a customer-centric approach, DR
US$ 26.91
US$ 25.04
US$ 29.70
US$ 28.87
